Peripheral Tolerization of Effector and Memory T Cells: Implications for Autoimmunity and Tumor-Immunity.
Due to the random generation of T cell antigen receptors, a large fraction of developing T cells have the potential to recognize self-determinants. To prevent this self-reactive T cell repertoire from mediating autoimmunity, the immune system utilizes several mechanisms to induce tolerance to self. The majority of self-reactive T cells undergo negative selection (i.e., apoptosis) during development if their antigen receptors have high affinity for MHC-self-peptide complexes present in the thymus. Nonetheless, some T cells recognize self-epitopes that are not present in the thymus, and will thus reach maturation and migrate to peripheral lymphoid organs were they can be subject to a number of peripheral tolerance mechanisms such as deletion, inactivation (i.e., anergy) or suppression. While peripheral tolerization of naive (i.e., antigen-inexperienced) T cells has been studied extensively, there are potential situations in which self-reactive T cells might first encounter immunogenic forms of antigen (deriving from pathogens or vaccines) and thus be programmed to develop effector and memory functions. This article will review recent studies that have explored the potential of effector and memory T cells to undergo peripheral tolerization, as well as potential implications of these findings for autoimmunity and tumor-immunity.
Adler
Adam J
AJ
Center for Immunotherapy of Cancer and Infectious Diseases, University of Connecticut Health Center, Farmington, Connecticut 06030, USA.
J Exp Med. 1998 May 18;187(10):1555-64
9584134
EMBO J. 1993 Jan;12(1):357-63
8428591
Cell. 1990 Dec 21;63(6):1249-56
2148123
J Immunol. 2004 Jun 1;172(11):6735-43
15153490
J Immunol. 2000 Jan 15;164(2):725-32
10623816
Eur J Immunol. 1991 Aug;21(8):1963-6
1907921
J Immunol. 1998 Jan 15;160(2):643-51
9551898
Immunity. 2000 Jun;12(6):677-86
10894167
J Exp Med. 1982 Apr 1;155(4):1063-74
6460831
J Immunol. 2002 Oct 1;169(7):3622-9
12244153
J Exp Med. 2003 Oct 6;198(7):1107-17
14530379
Science. 1991 Mar 8;251(4998):1225-8
1900951
Science. 2002 Oct 25;298(5594):850-4
12242449
Nature. 1988 Jun 23;333(6175):742-6
3260350
J Immunol. 1996 Oct 15;157(8):3280-9
8871622
J Exp Med. 2000 Jun 5;191(11):2021-7
10839816
J Immunol. 1999 Jul 15;163(2):723-7
10395663
J Exp Med. 1997 Mar 3;185(5):833-41
9120389
Science. 1994 Mar 18;263(5153):1615-8
8128249
Nat Med. 1999 Jul;5(7):774-9
10395322
Diabetes. 2000 Nov;49(11):1801-9
11078446
Nat Rev Immunol. 2001 Nov;1(2):135-45
11905821
Blood. 2000 Mar 15;95(6):2024-30
10706870
Annu Rev Immunol. 1994;12:991-1045
8011301
Blood. 2001 Aug 15;98(4):1070-7
11493453
Science. 1995 Mar 10;267(5203):1449-56
7533326
J Clin Invest. 2002 Jul;110(2):157-9
12122106
J Immunol. 2002 Jan 15;168(2):651-60
11777958
J Exp Med. 1997 Jul 21;186(2):239-45
9221753
Annu Rev Immunol. 2003;21:807-39
12615893
J Clin Invest. 1998 Jan 15;101(2):429-41
9435316
J Immunol. 1999 Aug 1;163(3):1178-87
10415012
Cell. 1987 Apr 24;49(2):273-80
3494522
J Clin Invest. 2002 Jul;110(2):185-92
12122110
Nat Rev Immunol. 2004 Feb;4(2):123-32
15040585
J Immunol. 1999 Feb 15;162(4):2024-34
9973474
J Exp Med. 2001 Jun 4;193(11):F41-6
11390442
Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1178-83
9448305
J Exp Med. 1994 Sep 1;180(3):995-1004
8064245
J Exp Med. 1996 Dec 1;184(6):2141-51
8976170
Cell Immunol. 2003 Aug;224(2):114-21
14609577
Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6187-91
11959916
J Immunol. 2000 Jan 15;164(2):649-55
10623806
Annu Rev Immunol. 2002;20:197-216
11861602
Cell. 1995 Mar 10;80(5):695-705
7534214
J Exp Med. 2002 Oct 21;196(8):1099-104
12391021
Immunity. 1996 May;4(5):445-54
8630730
Annu Rev Immunol. 2003;21:305-34
12471050
Cancer Res. 2002 Jul 15;62(14):3914-9
12124318
Cell. 2000 May 26;101(5):455-8
10850488
Lymphokine Res. 1986 Fall;5(4):289-99
2946903
Cancer Immunol Immunother. 1990;31(2):121-7
2138931
Nature. 1994 Nov 3;372(6501):100-3
7969401
Immunity. 1998 Jan;8(1):89-95
9462514
J Immunol. 1996 Aug 15;157(4):1406-14
8759720
Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16168-73
12427970
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3854-8
10097127
Nat Med. 2002 May;8(5):509-13
11984596
Immunol Rev. 2003 Jun;193:58-69
12752671
J Exp Med. 1998 Dec 21;188(12):2357-68
9858522
Immunity. 2001 Jul;15(1):137-47
11485745
J Immunol. 2002 Jun 1;168(11):5573-81
12023353
Cell. 1991 Apr 19;65(2):319-31
1901765
J Immunol. 2001 Jun 15;166(12):7370-80
11390488
Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8987-91
8415642
J Exp Med. 1997 Feb 3;185(3):531-9
9053453
Nat Immunol. 2002 Oct;3(10):940-3
12244309
J Exp Med. 2001 Sep 17;194(6):707-17
11560988
Nat Med. 2001 Aug;7(8):907-12
11479622
Cell. 1991 Apr 19;65(2):305-17
1901764
Nat Med. 1999 Jul;5(7):780-7
10395323
Nature. 2001 Mar 1;410(6824):101-5
11242050
Curr Opin Immunol. 1997 Oct;9(5):702-8
9368780
Eur J Immunol. 1999 Sep;29(9):2886-96
10508263
Annu Rev Immunol. 2001;19:23-45
11244029
Immunol Today. 1997 Dec;18(12):599-604
9425739
J Exp Med. 1996 Sep 1;184(3):923-30
9064352
J Immunol. 1984 Dec;133(6):3401-7
6149246
Science. 1999 Feb 26;283(5406):1335-9
10037605
J Immunol. 2003 Feb 15;170(4):2004-13
12574370
J Exp Med. 1993 Jun 1;177(6):1681-90
8496686
Cytokine Growth Factor Rev. 2002 Apr;13(2):95-109
11900986
Nature. 1996 Jan 25;379(6563):343-6
8552189
Immunity. 2002 Jul;17(1):73-81
12150893
Science. 2002 Nov 15;298(5597):1395-401
12376594
Eur J Immunol. 1990 May;20(5):1111-8
1972679
J Exp Med. 2001 Sep 17;194(6):769-79
11560993
J Immunol. 1994 Mar 15;152(6):2675-85
7908301
Science. 1998 Jul 31;281(5377):703-6
9685265
Science. 1996 Apr 5;272(5258):60-6
8600538
Science. 1994 Feb 25;263(5150):1139-43
7509084
J Immunol. 2000 Jan 1;164(1):107-12
10605000
J Immunol. 2004 May 1;172(9):5338-45
15100273
J Immunol. 2001 Feb 1;166(3):1439-42
11160180